Transgene SA

€0.75As of Sun 8 Nov 2026, 12:00 UTC
EPA:TNGHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (11.77%)
Div yield —
ROE (64.21%)
Biotechnology
Beta (5Y) 0.79
PE TTM —
TSR TTM (44.18%)
Mkt cap €204.9M
ROIC (31.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.81
8.22%
(45.32%)
Hold 0|1|4|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.02
0.02
(5.31%)
1.42%
12.20%
13.46%
Revenue€M
14.90
15.20
15.48
15.78
9.55%
5.43%
4.61%
3.39%
Peers (US$230.0M)
Cap (US$)
PE
132.1M
—
102.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.558
0.356
0.352
EBIT/Intx
0.174
0.102
0.131
Own earn%
7.63
(53.18)
(23.22)
Sh yield%
46.66
44.35
43.44
Owners
Insiders/Inst%
10.19
45.03
Short interest%
4.66
SBC / revenue%
2.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
12–19
$1 testx
0.0
Incr. ROIC%
0